Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease

CONCLUSIONS: This new set of metabolic markers reliably predicts the presence of cancer in arthritis or PN patients with high sensitivity and specificity and has the potential to facilitate a rapid and correct diagnosis of …